Recombinant hepatitis B vaccine (Yunnan Walvax Biotech)
重组乙型肝炎疫苗（云南沃森生物技术股份有限公司）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant hepatitis B vaccine (Yunnan Walvax Biotech)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesWalvax Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesWalvax Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A